Medicare Use Of Gross Rx Prices In Negotiation Picks Would Limit Savings, Erode Rebates – Payers

United Health Group and CVS strongly object to CMS’s proposed approach to selecting Part D drugs for price negotiation. United Health suggests the agency's method of announcing it will use gross, instead of net, costs could constitute a violation of the Administrative Procedure Act.

Part D Sponsors Worry They Will Lose Rebate Negotiation Leverage • Source: Shutterstock

The Centers for Medicare and Medicaid Services should reverse its proposal to base the selection of drugs eligible for Medicare price negotiation in Part D on gross spending before rebates rather than on net costs, two large Part D plan sponsors with major pharmacy benefit manager subsidiaries argue in recent comments to the agency.

CMS included the policy in its proposed rule on Medicare Advantage and Part D policy and technical changes for 2024...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet